Entrada Therapeutics, Inc. (TRDA) Insider Trading

Over the last 3 months, TRDA insiders made 0 open-market buys and 21 sales, a net sale of -$5.3M (SEC Form 4). Over the last 6 months, 101 institutions increased and 66 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
21
Net (3m)
-$5.3M
Insider trades by month Buys Sells
Jul
Nov
Mar
Apr
May
Aug
Context3-month price -1.1%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Aug 31, 2026MPM BioVentures 2014, L.P.10 percent ownerSell38,922$7.20
Aug 31, 2026MPM BioVentures 2014, L.P.10 percent ownerSell3,733$7.01
Aug 31, 2026MPM BIOVENTURES 2018, L.P.10 percent ownerSell38,922$7.20
Aug 31, 2026MPM BIOVENTURES 2018, L.P.10 percent ownerSell44,259$6.99
Aug 31, 2026MPM BioVentures 2014, L.P.10 percent ownerSell44,259$6.99
Aug 31, 2026MPM BIOVENTURES 2018, L.P.10 percent ownerSell3,733$7.01
Aug 26, 2026MPM BIOVENTURES 2018, L.P.10 percent ownerSell26,522$7.54
Aug 26, 2026MPM BIOVENTURES 2018, L.P.10 percent ownerSell21,623$7.34
Aug 26, 2026MPM BioVentures 2014, L.P.10 percent ownerSell14,569$7.06
Aug 26, 2026MPM BioVentures 2014, L.P.10 percent ownerSell26,522$7.54
Aug 26, 2026MPM BioVentures 2014, L.P.10 percent ownerSell21,623$7.34
Aug 26, 2026MPM BIOVENTURES 2018, L.P.10 percent ownerSell14,569$7.06
Aug 10, 20265AM Ventures V, L.P.10 percent ownerSell52,317$6.85
Aug 10, 2026PARMAR KUSHdirectorSell10,494$7.00
Aug 10, 20265AM Ventures V, L.P.10 percent ownerSell10,494$7.00
Aug 10, 2026PARMAR KUSHdirectorSell52,317$6.85
Aug 10, 2026PARMAR KUSHdirectorSell92,444$7.00
Aug 3, 2026PARMAR KUSHdirector, 10 percent owner: Sell1,718$6.85
Aug 3, 2026PARMAR KUSHdirector, 10 percent owner: Sell114,756$6.93
Aug 3, 20265AM Ventures V, L.P.10 percent ownerSell1,718$6.85
Aug 3, 20265AM Ventures V, L.P.10 percent ownerSell114,756$6.93
Jun 12, 2026Radhakrishnan MahadirectorGrant19,000$5.97
Jun 12, 2026KIM PETER SdirectorGrant19,000$5.97
Jun 12, 2026PARMAR KUSHdirector, 10 percent owner: Grant19,000$5.97
Jun 12, 2026Zeiher Bernhardt GdirectorGrant19,000$5.97
Jun 12, 2026Thistle MarydirectorGrant19,000$5.97
Jun 12, 2026Chapman GinadirectorGrant19,000$5.97
May 21, 2026Zeiher Bernhardt GdirectorBuy5,000$5.86
May 4, 2026Dowden Nathan Jofficer: President & COOSell15,000$15.33
May 4, 2026Sethuraman Natarajanofficer: President, Research & Develop.Sell25,907$15.39

Source: TRDA SEC Form 4 filings, latest Aug 31, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their TRDA positions over the last 6 months (SEC Form 13F).

Increased
101
New positions
47
Reduced
66
Sold out
16
Largest moves
InstitutionActionSharesFiled
BAKER BROS. ADVISORS LPUnchanged5.1MAug 14, 2026
BAKER BROS. ADVISORS LPUnchanged5.1MMay 15, 2026
5AM Venture Management, LLCUnchanged4.1MAug 14, 2026
5AM VENTURE MANAGEMENT, LLCUnchanged4.1MMay 15, 2026
BlackRock, Inc.Increased2.6MAug 7, 2026
BLACKROCK, INC.Increased2.4MMay 13, 2026
TCG CROSSOVER MANAGEMENT, LLCIncreased2.3MMay 15, 2026
Merck & Co., Inc.New Position1.7MAug 7, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1.3MAug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1.3MMay 15, 2026
MPM BioImpact LLCNew Position1.3MAug 14, 2026
TCG Crossover Management, LLCReduced1.1MAug 14, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced1.0MMay 15, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced954KAug 14, 2026
MILLENNIUM MANAGEMENT LLCIncreased764KAug 14, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.